An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma
NCT03968315 is an interventional trial sponsored by M.D. Anderson Cancer Center. As of 21 Nov 2026, it is active and no longer recruiting. It studies Recurrent Malignant Thymoma and Thymoma. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 8 Jun 2011 and a primary completion date of 30 Apr 2029.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03968315 |
| Status | Active not recruiting |
| Study type | Interventional trial |
| Lead sponsor | M.D. Anderson Cancer Center |
| Enrollment | 40 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Recurrent Malignant Thymoma and Thymoma |
| Start | 8 Jun 2011 |
| Primary completion | 30 Apr 2029 |
| Study completion | 30 Apr 2029 |
| Last update posted | 18 Sept 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Marcelo F Benveniste
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- M D Anderson Cancer Center
Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03968315
Each answer restates registry values shown on this page.
What is NCT03968315?
NCT03968315 is an interventional trial sponsored by M.D. Anderson Cancer Center. It studies Recurrent Malignant Thymoma and Thymoma.
Is NCT03968315 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT03968315?
The registry names Marcelo F Benveniste (principal investigator, M.D. Anderson Cancer Center) as the overall official.
Where does NCT03968315 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT03968315 expected to complete?
The registry lists a primary completion date of 30 Apr 2029 and a study completion date of 30 Apr 2029. The sponsor last updated the record on 18 Sept 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.